22nd century group (nasdaq: xxii) appoints r. hugh kinsman as cfo

Buffalo, n.y., june 16, 2022 (globe newswire) -- 22nd century group, inc. (nasdaq: xxii), a leading agricultural biotechnology company), dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the appointment of r. hugh kinsman as chief financial officer. kinsman is currently cfo of gvb biopharma, which 22nd century acquired effective may 13, 2022.
XXII Ratings Summary
XXII Quant Ranking